WELLlife™ COVID-19 / Influenza A&B Antigen Test (Point of Care)

The WELLlife™ COVID-19 / Influenza A&B Antigen Test is a rapid, high-performance diagnostic tool designed to help healthcare professionals quickly differentiate between SARS-CoV-2, Influenza A, and Influenza B from a single anterior nasal swab. This easy-to-use lateral flow immunoassay delivers clear, dependable results in just 10 minutes, supporting fast clinical decision-making and timely patient care.

Built for accuracy and reliability, the test features separate detection lines for COVID-19, Flu A, and Flu B, along with a built-in control line that ensures proper test function. With an **extended detection window—up to four days from symptom onset—**and wide room-temperature storage (36°F–86°F / 2°C–30°C), the WELLlife™ test offers both flexibility and operational convenience in clinical settings.

The test is intended for use with symptomatic patients and provides a cost-effective solution for differentiating common respiratory infections that often present with similar symptoms.

Professional Use | 510(k) Cleared

Key Features & Benefits

• Rapid 10-Minute Results
  Enables diagnosis and treatment decisions during the same patient visit.

• Triple-Target Detection
  Differentiates SARS-CoV-2, Influenza A, and Influenza B using a single nasal swab.

• High Accuracy & Quality Assurance
  510(k) cleared for professional use and supported by internal control lines plus optional external control kits for quality monitoring.
  
  
• Extended Detection Window
  Optimized for patients tested within four (4) days of symptom onset, improving clinical utility.
  
  
• Wide Storage Range
  Stable between 36°F–86°F (2°C–30°C), enabling easy storage without special refrigeration.
  
  
• Simple, Streamlined Workflow
  Uses anterior nasal swab collection with straightforward sample processing and visual result interpretation.
  
  

  For professional in vitro diagnostic use to qualitatively detect and differentiate:

  • SARS-CoV-2 nucleocapsid antigen

  • Influenza A nucleoprotein antigen

  • Influenza B nucleoprotein antigen

  The test is intended for patients aged 14+ self-testing, or ages 2+ when the sample is collected by an adult in a professional setting.